Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
about
Characterization of a functional thrombin receptor. Issues and opportunitiesTherapeutic Implications of a Specific Murine Monoclonal Antibody (7E3) to the Platelet Receptor GPIIb/IIIa.Antiplatelet therapy--Part ISystemic lysis protects against the effects of platelet activation during coronary thrombolysis.Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.Thrombin receptor expression in normal and atherosclerotic human arteries.Critical review of mouse models of venous thrombosis.Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complexPlatelets and fibrinolysis.Proinflammatory signaling functions of thrombin in cancer.Modeling thrombus formation and growth.Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.Thrombin and antithrombotic therapy in interventional cardiology.Specific thrombin inhibitors in vivo.Antithrombotic effect of a novel recombinant hirudin analogue, CX-397, in a rat arterial thrombosis model.Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.Prediction of Thrombus Growth: Effect of Stenosis and Reynolds Number.Search for an animal model to investigate selective pulmonary vasodilation.
P2860
Q24561385-421E876F-1A8A-4443-B0CE-83A3EC42363DQ33392640-EAB9C06E-9411-4F4A-B03A-BCDDA94AD535Q33606832-0EC04DE6-C0FF-489B-8E15-72B2E92ED1B8Q34208881-7CC6126E-13C4-432B-9845-19A3E5C89F2EQ34536091-566970AB-7F39-4A6C-B118-4B823681FD6DQ35607594-66FCEC0C-E319-4756-8AEC-5AE0AEA29029Q35796005-EE09C2B9-EAD1-41AA-9C60-E5B10F6B207DQ35805471-E907ED4D-0B4A-4BDF-9EAE-778EC6A6A3D0Q37806238-5A843F2B-13E4-46EC-AC47-85553B3CC383Q39048394-4E0DCEC6-48C1-427E-BED4-AED10A02BC6EQ39329081-B84C9890-9815-40B1-9187-A288153AE79EQ40342837-9A7EE555-79C2-4FFC-ADC5-DAE87518FDF5Q40486965-EF8C60A4-D433-46A4-BB99-3D7AD92136F0Q40664734-81561944-B1AE-401C-94BA-4CA232700947Q41834459-303D7278-2CBE-4AF2-A741-F928F220AB58Q41865617-B570BE49-3C1A-4089-AF64-6B54B325AF73Q42717484-DDC2B693-944B-409B-A64E-D05DD2C7EE16Q45058323-1122F411-B133-4024-932D-7CC5615989CDQ47360550-DF1C7749-A31E-49BD-9615-BF89EBBD643F
P2860
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@ast
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@en
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@nl
type
label
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@ast
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@en
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@nl
prefLabel
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@ast
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@en
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@nl
P2860
P356
P1476
Role of thrombin and thromboxa ...... ue-type plasminogen activator.
@en
P2093
D J Fitzgerald
G A Fitzgerald
P2860
P304
P356
10.1073/PNAS.86.19.7585
P407
P577
1989-10-01T00:00:00Z